A citation-based method for searching scientific literature

David A Hinds, Kimberly E Barnholt, Ruben A Mesa, Amy K Kiefer, Chuong B Do, Nicholas Eriksson, Joanna L Mountain, Uta Francke, Joyce Y Tung, Huong Marie Nguyen, Haiyu Zhang, Linda Gojenola, James L Zehnder, Jason Gotlib. Blood 2016
Times Cited: 118







List of co-cited articles
1156 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
49

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Giulio Genovese, Anna K Kähler, Robert E Handsaker, Johan Lindberg, Samuel A Rose, Samuel F Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M Neale, Menachem Fromer,[...]. N Engl J Med 2014
42

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms.
William Tapper, Amy V Jones, Robert Kralovics, Ashot S Harutyunyan, Katerina Zoi, William Leung, Anna L Godfrey, Paola Guglielmelli, Alison Callaway, Daniel Ward,[...]. Nat Commun 2015
111
39

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, Christopher J Gibson, Alexander G Bick, Eugenia Shvartz, Marie McConkey, Namrata Gupta, Stacey Gabriel, Diego Ardissino,[...]. N Engl J Med 2017
843
39

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
36

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.
Amy V Jones, Andrew Chase, Richard T Silver, David Oscier, Katerina Zoi, Y Lynn Wang, Holger Cario, Heike L Pahl, Andrew Collins, Andreas Reiter,[...]. Nat Genet 2009
279
35

Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Mingchao Xie, Charles Lu, Jiayin Wang, Michael D McLellan, Kimberly J Johnson, Michael C Wendl, Joshua F McMichael, Heather K Schmidt, Venkata Yellapantula, Christopher A Miller,[...]. Nat Med 2014
961
34

Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.
Florian Zink, Simon N Stacey, Gudmundur L Norddahl, Michael L Frigge, Olafur T Magnusson, Ingileif Jonsdottir, Thorgeir E Thorgeirsson, Asgeir Sigurdsson, Sigurjon A Gudjonsson, Julius Gudmundsson,[...]. Blood 2017
308
29

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
28

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
Outi Kilpivaara, Semanti Mukherjee, Alison M Schram, Martha Wadleigh, Ann Mullally, Benjamin L Ebert, Adam Bass, Sachie Marubayashi, Adriana Heguy, Guillermo Garcia-Manero,[...]. Nat Genet 2009
256
27

A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Robert Kralovics, Francesco Passamonti, Andreas S Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R Passweg, Andre Tichelli, Mario Cazzola, Radek C Skoda. N Engl J Med 2005
26

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
David P Steensma, Rafael Bejar, Siddhartha Jaiswal, R Coleman Lindsley, Mikkael A Sekeres, Robert P Hasserjian, Benjamin L Ebert. Blood 2015
862
26

The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms.
A Oddsson, S Y Kristinsson, H Helgason, D F Gudbjartsson, G Masson, A Sigurdsson, A Jonasdottir, A Jonasdottir, H Steingrimsdottir, B Vidarsson,[...]. Leukemia 2014
66
36

Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.
Andrew L Young, Grant A Challen, Brenda M Birmann, Todd E Druley. Nat Commun 2016
300
24

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
José J Fuster, Susan MacLauchlan, María A Zuriaga, Maya N Polackal, Allison C Ostriker, Raja Chakraborty, Chia-Ling Wu, Soichi Sano, Sujatha Muralidharan, Cristina Rius,[...]. Science 2017
517
23

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli,[...]. Nature 2005
22

Somatic mutations of calreticulin in myeloproliferative neoplasms.
Thorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, Harini Nivarthi, Elisa Rumi, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Bettina Gisslinger, Daniela Pietra,[...]. N Engl J Med 2013
22

Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis.
Thomas McKerrell, Naomi Park, Thaidy Moreno, Carolyn S Grove, Hannes Ponstingl, Jonathan Stephens, Charles Crawley, Jenny Craig, Mike A Scott, Clare Hodkinson,[...]. Cell Rep 2015
295
22

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.
E Joanna Baxter, Linda M Scott, Peter J Campbell, Clare East, Nasios Fourouclas, Soheila Swanton, George S Vassiliou, Anthony J Bench, Elaine M Boyd, Natasha Curtin,[...]. Lancet 2005
20

Effect of mutation order on myeloproliferative neoplasms.
Christina A Ortmann, David G Kent, Jyoti Nangalia, Yvonne Silber, David C Wedge, Jacob Grinfeld, E Joanna Baxter, Charles E Massie, Elli Papaemmanuil, Suraj Menon,[...]. N Engl J Med 2015
296
20

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
Linda M Scott, Wei Tong, Ross L Levine, Mike A Scott, Philip A Beer, Michael R Stratton, P Andrew Futreal, Wendy N Erber, Mary Frances McMullin, Claire N Harrison,[...]. N Engl J Med 2007
862
20

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Pontus Lundberg, Axel Karow, Ronny Nienhold, Renate Looser, Hui Hao-Shen, Ina Nissen, Sabine Girsberger, Thomas Lehmann, Jakob Passweg, Martin Stern,[...]. Blood 2014
380
19

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.
Damla Olcaydu, Ashot Harutyunyan, Roland Jäger, Tiina Berg, Bettina Gisslinger, Ingrid Pabinger, Heinz Gisslinger, Robert Kralovics. Nat Genet 2009
255
19

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.
Catherine C Coombs, Ahmet Zehir, Sean M Devlin, Ashwin Kishtagari, Aijazuddin Syed, Philip Jonsson, David M Hyman, David B Solit, Mark E Robson, José Baselga,[...]. Cell Stem Cell 2017
272
19

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Ross L Levine, Martha Wadleigh, Jan Cools, Benjamin L Ebert, Gerlinde Wernig, Brian J P Huntly, Titus J Boggon, Iwona Wlodarska, Jennifer J Clark, Sandra Moore,[...]. Cancer Cell 2005
18

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Yana Pikman, Benjamin H Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky,[...]. PLoS Med 2006
989
18

Prediction of acute myeloid leukaemia risk in healthy individuals.
Sagi Abelson, Grace Collord, Stanley W K Ng, Omer Weissbrod, Netta Mendelson Cohen, Elisabeth Niemeyer, Noam Barda, Philip C Zuzarte, Lawrence Heisler, Yogi Sundaravadanam,[...]. Nature 2018
298
18

Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations.
Po-Ru Loh, Giulio Genovese, Robert E Handsaker, Hilary K Finucane, Yakir A Reshef, Pier Francesco Palamara, Brenda M Birmann, Michael E Talkowski, Samuel F Bakhoum, Steven A McCarroll,[...]. Nature 2018
114
18

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Elisa Rumi, Daniela Pietra, Virginia Ferretti, Thorsten Klampfl, Ashot S Harutyunyan, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Chiara Elena, Ilaria C Casetti,[...]. Blood 2014
375
17


DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.
Manuel Buscarlet, Sylvie Provost, Yassamin Feroz Zada, Amina Barhdadi, Vincent Bourgoin, Guylaine Lépine, Luigina Mollica, Natasha Szuber, Marie-Pierre Dubé, Lambert Busque. Blood 2017
154
17

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.
Lambert Busque, Jay P Patel, Maria E Figueroa, Aparna Vasanthakumar, Sylvie Provost, Zineb Hamilou, Luigina Mollica, Juan Li, Agnes Viale, Adriana Heguy,[...]. Nat Genet 2012
505
16

Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
Soichi Sano, Kosei Oshima, Ying Wang, Susan MacLauchlan, Yasufumi Katanasaka, Miho Sano, María A Zuriaga, Minoru Yoshiyama, David Goukassian, Matthew A Cooper,[...]. J Am Coll Cardiol 2018
210
16

The origin and evolution of mutations in acute myeloid leukemia.
John S Welch, Timothy J Ley, Daniel C Link, Christopher A Miller, David E Larson, Daniel C Koboldt, Lukas D Wartman, Tamara L Lamprecht, Fulu Liu, Jun Xia,[...]. Cell 2012
16

Detectable clonal mosaicism and its relationship to aging and cancer.
Kevin B Jacobs, Meredith Yeager, Weiyin Zhou, Sholom Wacholder, Zhaoming Wang, Benjamin Rodriguez-Santiago, Amy Hutchinson, Xiang Deng, Chenwei Liu, Marie-Josephe Horner,[...]. Nat Genet 2012
360
16

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Kelly Moran-Crusio, Linsey Reavie, Alan Shih, Omar Abdel-Wahab, Delphine Ndiaye-Lobry, Camille Lobry, Maria E Figueroa, Aparna Vasanthakumar, Jay Patel, Xinyang Zhao,[...]. Cancer Cell 2011
786
16

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.
Ofir Wolach, Rob S Sellar, Kimberly Martinod, Deya Cherpokova, Marie McConkey, Ryan J Chappell, Alexander J Silver, Dylan Adams, Cecilia A Castellano, Rebekka K Schneider,[...]. Sci Transl Med 2018
140
16

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.
Jelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, Emilie Leroy, Elisa Rumi, Ilyas Chachoua, Klaudia Bagienski, Blanka Kubesova, Daniela Pietra, Bettina Gisslinger,[...]. Blood 2016
155
15

Detectable clonal mosaicism from birth to old age and its relationship to cancer.
Cathy C Laurie, Cecelia A Laurie, Kenneth Rice, Kimberly F Doheny, Leila R Zelnick, Caitlin P McHugh, Hua Ling, Kurt N Hetrick, Elizabeth W Pugh, Chris Amos,[...]. Nat Genet 2012
362
15

Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.
Elisa Rumi, Francesco Passamonti, Matteo G Della Porta, Chiara Elena, Luca Arcaini, Laura Vanelli, Cecilia Del Curto, Daniela Pietra, Emanuela Boveri, Cristiana Pascutto,[...]. J Clin Oncol 2007
101
14

Dnmt3a is essential for hematopoietic stem cell differentiation.
Grant A Challen, Deqiang Sun, Mira Jeong, Min Luo, Jaroslav Jelinek, Jonathan S Berg, Christoph Bock, Aparna Vasanthakumar, Hongcang Gu, Yuanxin Xi,[...]. Nat Genet 2011
656
14

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
14

Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
Jacob Grinfeld, Jyoti Nangalia, E Joanna Baxter, David C Wedge, Nicos Angelopoulos, Robert Cantrill, Anna L Godfrey, Elli Papaemmanuil, Gunes Gundem, Cathy MacLean,[...]. N Engl J Med 2018
224
14

Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.
Ann Mullally, Steven W Lane, Brian Ball, Christine Megerdichian, Rachel Okabe, Fatima Al-Shahrour, Mahnaz Paktinat, J Erika Haydu, Elizabeth Housman, Allegra M Lord,[...]. Cancer Cell 2010
248
13

Targeted deep sequencing in polycythemia vera and essential thrombocythemia.
Ayalew Tefferi, Terra L Lasho, Paola Guglielmelli, Christy M Finke, Giada Rotunno, Yoseph Elala, Annalisa Pacilli, Curtis A Hanson, Alessandro Pancrazzi, Rhett P Ketterling,[...]. Blood Adv 2016
160
13

Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
Joseph Saliba, Cécile Saint-Martin, Antonio Di Stefano, Gaëlle Lenglet, Caroline Marty, Boris Keren, Florence Pasquier, Véronique Della Valle, Lise Secardin, Gwendoline Leroy,[...]. Nat Genet 2015
73
17

Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.
Qian Zhang, Kai Zhao, Qicong Shen, Yanmei Han, Yan Gu, Xia Li, Dezhi Zhao, Yiqi Liu, Chunmei Wang, Xiang Zhang,[...]. Nature 2015
365
13

Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population.
Camilla Nielsen, Henrik S Birgens, Børge G Nordestgaard, Stig E Bojesen. Br J Haematol 2013
54
24

Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.
Robert L Bowman, Lambert Busque, Ross L Levine. Cell Stem Cell 2018
194
13

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Christopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, Brenton G Mar, Jiantao Shi, Siddhartha Jaiswal, Alysia Bosworth, Liton Francisco, Jianbo He, Anita Bansal,[...]. J Clin Oncol 2017
186
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.